HLA-A*02 subtype distribution in Caucasians from northern Italy: Identification of A*0220

Tissue Antigens

Volumn 48, Issue 6, 1996, Pages 673-679

  Fleischhauer, K ^a   Zino, E ^a   Mazzi, B ^a   Severini, G M ^a   Benazzi, E ^a   Bordignon, C ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

A*0220; HLA A2 subtypes; PCR SSOP; Population study

Indexed keywords

HLA A2 ANTIGEN; LYSINE; VACCINE;

AMINO ACID SEQUENCE; ARTICLE; BONE MARROW TRANSPLANTATION; CAUCASIAN; CODON; DNA SEQUENCE; DONOR; EXON; GENE AMPLIFICATION; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOTHERAPY; ITALY; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; SEROLOGY; CLASSIFICATION; GENE; GENETICS;

EUROPEAN CONTINENTAL ANCESTRY GROUP; GENES; HLA-A2 ANTIGEN; HUMANS; ITALY; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION;

EID: 0030300032     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02691.x     Document Type: Article

References (27)

1. Lopez de Castro JA. HLA-B27 and HLA-A2 subtypes: structure, evolution and function. Immunol Today 1989: 124: 239-43.
2. Imanishi I, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992: 1065-220.
3. Bodmer JG, Marsh SGE, Albert ED, et al. Nomenclature for factors of the HLA system, 1995. Hum Immunol 1995: 43: 149-64.
4. Roetzschke O, Falk K, Stevanovic S, Jung G, Rammensee HG. Peptide motifs of closely related HLA class I molecules encompass substantial differences. Eur J Immunol 1992: 22: 2453-6.
5. Tanigaki N, Fruci D, Chersi A, Falasca G, Tosi R, Butler RH. HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products. Hum Immunol 1994: 39: 155-62.
6. del Guercio MF, Sidney J, Hermanson G et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 1995: 154: 685-93.
7. Barouch D, Friede T, Stevanovic S et al. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J Exp Med 1995: 182: 1847-56.
8. Mattson DH, Shimojo N, Cowan EP et al. Differential effects of amino acid substitutions in the β-sheet floor and α-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes. J Immunol 1989: 143: 1101-7.
9. McMichael AJ, Gotch FM, Santos-Aguado J, Strominger JL. Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 1988: 85: 9194-8.
10. Matsui M, Moots RJ, Warburton RJ, Peace-Brewer AL et al. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition. J Immunol 1995: 154: 1088-96.
11. + cytotoxic T cell line. J Immunol (in press).
12. Rivoltini L, Loftus DJ, Barracchini K et al. Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy. J Immunol 1996: 156: 3882-91.
13. Santos-Aguado J, Crimmins MAV, Mentzer SJ, Burakoff SJ, Strominger JL. Alloreactivity studied with mutants of HLA-A2. Proc Natl Acad Sci U S A 1989: 86: 8936-40.
14. Yang SY. Population analysis of class I HLA antigens by one-dimensional isoelectric focusing gel electrophoreses: workshop summary report. In: Dupont B, ed. Immunobiology of HLA, Vol. 1: Histocompatibility testing 1987. Berlin: Springer, 1989: 54-5.
15. Fernandez-Vina MA, Falco M, Sun Y, Stastny P. DNA typing for HLA class I alleles. I. Subsets of HLA-A2 and of-A28. Hum Immunol 1992: 33: 163-73.
16. Tiercy JM, Djavad N, Rufer N, Speiser D, Jeannet M, Roosnek E. Oligotyping of HLA-A2, -A3, and -B44 subtypes. Detection of subtype incompatibilities between patients and their serologically matched unrelated bone marrow donors. Hum Immunol 1994: 41: 207-15.
17. Krausa P, Brywka III M, Savage D et al. Genetic polymorphism within HLA-A*02: signifcant allelic variation revealed in different populations. Tissue Antigens 1995: 45: 223-31.
18. Oh S, Fleischhauer K, Yang SY. Isoelectric focusing subtypes of HLA-A can be defined by oligonucleotide typing. Tissue Antigens 1993: 41: 135-42.
19. Terasaki PI, Bernoro D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, B, C and D antigens. Am J Clin Pathol 1978: 69: 103-20.
20. Arnett KL, Parham P. HLA class I nucleotide sequences, 1995. Tissue Antigens 1995: 46: 217-57.
21. Fleischhauer K, Zino E, Bordignon C, Benazzi E. Complete generic and extensive fine-specificity typing of the HLA-B locus by the PCR-SSOP method. Tissue Antigens 1995: 46: 281-92.
22. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K., Aizawa M, Sasazuki T, ed. HLA 1991, Vol. 1: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992: 397-419.
23. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977: 74: 5463-7.
24. Carcassi C, Krausa P, Bodmer J, Browning M. Characterization of HLA-A*02 subtypes in the Sardinian population. Tissue Antigens 1995: 46: 391-3.
25. Selvakumar A, Granja CB, Salazar M, Alosco SM, Yunis EJ, Dupont B. A novel subtype of A2 (A*0217) isolated from the South American Indian B-cell line AMALA. Tissue Antigens 1995: 45: 343-7.
26. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY. Bone-marrow allograft rejection by cytotoxic T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 1990: 323: 1818-22.
27. Keever CA, Leong N, Cunningham I et al. HLA-B44-directed cytotoxic T cells associated with acute graft vs. host disease following unrelated bone marrow transplantation. Bone Marrow Transplant 1994: 14: 134-15.